Artem Yusupov, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 10825 72nd Ave, Ste 1a, Forest Hills, NY 11375 Phone: 347-561-9535 Fax: 347-561-9513 |
Dr. Barbara Goldstein, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11835 Queens Blvd, Suite 1430, Forest Hills, NY 11375 Phone: 718-773-8888 Fax: 718-261-1915 |
Dr. Carolyn Lindenbaum, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 7050 Austin St Ste Ll115, Forest Hills, NY 11375 Phone: 718-793-9629 |
Jsw Audiology Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 7050 Austin St, Forest Hills, NY 11375 Phone: 718-793-9629 Fax: 718-793-9665 |
Mr. Neil C Strauss, MS CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 10440 Queens Blvd, #1c, Forest Hills, NY 11375 Phone: 718-841-7487 Fax: 718-841-7487 |
Ms. Tuva Shimunova Audiologist Medicare: Not Enrolled in Medicare Practice Location: 10825 72nd Ave Ste 1a, Forest Hills, NY 11375 Phone: 347-561-9535 Fax: 347-561-9513 |
D & S Professionals Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 108-17 72nd Ave, #2e, Forest Hills, NY 11375 Phone: 718-997-7373 |
Mindy Lee Duboff, MA AUDIOLOGY Audiologist Medicare: May Accept Medicare Assignments Practice Location: 10721 Queens Blvd, Forest Hills, NY 11375 Phone: 718-520-1594 Fax: 718-520-8610 |
Jessica Ann Verkhovsky, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 107-21 Queens Boulevard, Suite 8, Forest Hills, NY 11375 Phone: 718-575-0777 |
News Archive
For the fifth year in a row, Cedars-Sinai Medical Group and Cedars-Sinai Health Associates have been awarded the highest possible designation for quality care by a leading national organization representing managed care physician groups. CAPG, formerly known as the California Association of Physician Groups, rated both Cedars-Sinai groups as excelling in all six of the criteria used in the 2014 Standards of Excellence survey.
A study from a team of researchers led by Dr. Andrew P. Makrigiannis, Director of the Molecular Immunology Research Unit at the IRCM, has identified a new mechanism regulating interferon production.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced that BioDiem has signed an agreement with The Royal Melbourne Institute of Technology (RMIT) regarding a research program that will investigate the use of BioDiem's live attenuated influenza virus (LAIV) to create new non-influenza vaccines. Developing the potential of the LAIV technology for new indications is an important part of BioDiem's strategy, and this research is part of the work towards that goal.
For the biopharmaceutical industry, the changing healthcare marketplace has increased the importance - and difficulty - of interacting with patients to improve outcomes. New technologies and access restrictions have created both opportunities and challenges for approaching and engaging patient populations to improve disease control.
› Verified 6 days ago